Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, animal health care specialist VCA Antech
With that in mind, let's take a closer look at VCA Antech's business and see what CAPS investors are saying about the stock right now.
VCA Antech facts
|Headquarters (founded)||Los Angeles (1986)|
|Market Cap||$1.8 billion|
|Trailing-12-Month Revenue||$1.5 billion|
|Management||Co-Founder/Chairman/CEO Robert Antin
Co-Founder/COO Arthur Antin
|Return on Equity (average, past 3 years)||12.3%|
|Cash/Debt||$72.7 million / $656.8 million|
Medical Management International
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 95% of the 241 members who have rated VCA Antech believe the stock will outperform the S&P 500 going forward.
This week, one of those Fools, All-Star latimerburned, tapped VCA Antech as a solid investment for the long haul: "Stock hasn't done as well as they just have not been able to turn their consolidation of the industry into steady profit growth. Long term trends toward pet ownership growth remains."
If you want market-thumping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong five-star rating, VCA Antech may not be your top choice.
If that's the case, we've compiled a special free report for investors called "Discover the Next Rule-Breaking Multibagger," which uncovers another growth play with big potential. The report is 100% free, but it won't be around forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of VCA Antech and PetSmart, as well as writing covered calls on VCA Antech. Try any of our Foolish newsletter services free for 30 days.